SCHEMBL25495509

SCHEMBL25495509

O=C(CCOCCOCCC(=O)Oc1c(F)c(F)cc(F)c1F)Oc1c(F)c(F)cc(F)c1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 3/20 0.36
▸ FFAR1 O14842 2/20 0.36
▸ MAPT P10636 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ HTT P42858 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ CA1 P00915 2/20 0.34
▸ CA2 P00918 2/20 0.34
▸ CA4 P22748 2/20 0.34
▸ SERPINE1 P05121 1/20 0.33
▸ CES2 O00748 1/20 0.32
▸ CES1 P23141 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ RARA P10276 1/20 0.31
▸ RARB P10826 1/20 0.31
▸ MAOB P27338 1/20 0.30
▸ VCAM1 P19320 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22770988 1.00 FFAR4 (0.36) FFAR4FFAR1MAPTALDH1A1HTT
SCHEMBL22771215 1.00 FFAR4 (0.36) FFAR4FFAR1MAPTALDH1A1HTT
SCHEMBL27145140 1.00 FFAR4 (0.36) FFAR4FFAR1MAPTALDH1A1HTT
SCHEMBL29606930 1.00 FFAR4 (0.36) FFAR4FFAR1MAPTALDH1A1HTT
SCHEMBL30771482 1.00 FFAR4 (0.36) FFAR4FFAR1MAPTALDH1A1HTT
SCHEMBL24120787 1.00 FFAR4 (0.36) FFAR4FFAR1MAPTALDH1A1HTT
SCHEMBL30771479 1.00 FFAR4 (0.36) FFAR4FFAR1MAPTALDH1A1HTT
SCHEMBL31261009 0.98 MAPT (0.36) FFAR4FFAR1MAPTALDH1A1HTT
SCHEMBL23289621 0.94 FFAR4 (0.41) FFAR4FFAR1MAPTALDH1A1HTT
SCHEMBL23813715 0.94 FFAR1 (0.33) FFAR4FFAR1MAPTALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025078841-A2 ANTIBODIES, CONJUGATES, AND USES THEREOF ANTIKOR BIOPHARMA LIMITED (GB) 2025-04-17 — — WO disclosed
US-20230158155-A1 Cell Surface Receptor Binding Compounds and Conjugates LYCIA THERAPEUTICS, INC. 2023-05-25 — — US disclosed
US-20230158155-A1 Cell Surface Receptor Binding Compounds and Conjugates LYCIA THERAPEUTICS, INC. 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158155-A1 Cell Surface Receptor Binding Compounds and Conjugates M6PR, ASGR1, IGF2R FFAR4 215/4885FFAR1 233/4885MAPT 3180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback